{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:56:23Z","timestamp":1789736183441,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1124\/jpet.102.033746","type":"journal-article","created":{"date-parts":[[2003,1,10]],"date-time":"2003-01-10T18:44:00Z","timestamp":1042224240000},"page":"751-758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Wild-Type and A328W Mutant Human Butyrylcholinesterase Tetramers Expressed in Chinese Hamster Ovary Cells Have a 16-Hour Half-Life in the Circulation and Protect Mice from Cocaine Toxicity"],"prefix":"10.1016","volume":"302","author":[{"given":"Ellen G.","family":"Duysen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia F.","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Lockridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.102.033746_bib1","doi-asserted-by":"crossref","first-page":"13414","DOI":"10.1021\/bi991475+","article-title":"Conserved aromatic residues of the C-terminus of butyrylcholinesterase mediate the association of tetramers.","volume":"38","author":"Altamirano","year":"1999","journal-title":"Biochemistry"},{"key":"10.1124\/jpet.102.033746_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1213\/00000539-199201000-00022","article-title":"Succinylcholine-induced prolonged apnea in a 3-week-old newborn: treatment with human plasma cholinesterase.","volume":"74","author":"Benzer","year":"1992","journal-title":"Anesth Analg"},{"key":"10.1124\/jpet.102.033746_bib3","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1042\/bj3270747","article-title":"Tetramerization domain of human butyrylcholinesterase is at the C-terminus.","volume":"327","author":"Blong","year":"1997","journal-title":"Biochem J"},{"key":"10.1124\/jpet.102.033746_bib4","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1074\/jbc.272.5.3016","article-title":"Quaternary associations of acetylcholinesterase. II. The polyproline attachment domain of the collagen tail.","volume":"272","author":"Bon","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.102.033746_bib5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00000542-195505000-00014","article-title":"The interrelationship of succinylcholine and the blood cholinesterases during anesthesia.","volume":"16","author":"Borders","year":"1955","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.102.033746_bib6","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/0091-3057(93)90218-I","article-title":"Prevention of soman-induced cognitive deficits by pretreatment with human butyrylcholinesterase in rats.","volume":"46","author":"Brandeis","year":"1993","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.102.033746_bib7","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0022-3565(25)20479-7","article-title":"Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates.","volume":"259","author":"Broomfield","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.033746_bib8","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1037\/1064-1297.6.3.274","article-title":"Attenuation of cocaine-induced locomotor activity by butyrylcholinesterase.","volume":"6","author":"Carmona","year":"1998","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1124\/jpet.102.033746_bib9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0091-3057(97)00604-7","article-title":"Cocaine sensitization can accelerate the onset of peak cocaine behavioral effects.","volume":"60","author":"Carey","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.102.033746_bib10","first-page":"337","article-title":"L\u2019uso delle colinesterasi sieriche nella intossicazione grave da organofosforici nostra esperienze.","volume":"54","author":"Cascio","year":"1988","journal-title":"Minerva Anestesiol"},{"key":"10.1124\/jpet.102.033746_bib11","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1042\/bj3570795","article-title":"Effect of chemical modification of recombinant human acetylcholinesterase by polyethylene glycol on its circulatory longevity.","volume":"357","author":"Cohen","year":"2001","journal-title":"Biochem J"},{"key":"10.1124\/jpet.102.033746_bib12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0149-7634(05)80103-4","article-title":"Enzymes as pretreatment drugs for organophosphate toxicity.","volume":"15","author":"Doctor","year":"1991","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/jpet.102.033746_bib13","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0022-3565(24)29259-4","article-title":"Evidence for non-acetylcholinesterase targets of organophosphorus nerve agent; supersensitivity of the acetylcholinesterase knockout mouse to VX lethality.","volume":"299","author":"Duysen","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.033746_bib14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity.","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.102.033746_bib15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/bmj.1.4802.136","article-title":"Effect of pseudo-cholinesterase level on action of succinylcholine in man.","volume":"1","author":"Evans","year":"1953","journal-title":"Br Med J"},{"key":"10.1124\/jpet.102.033746_bib16","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/0006-2952(91)90665-R","article-title":"Activities of the enantiomers of cocaine and some related compounds as substrates and inhibitors of plasma butyrylcholinesterase.","volume":"41","author":"Gatley","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.102.033746_bib17","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1749-6632.1971.tb46945.x","article-title":"Suxamethonium sensitivity.","volume":"179","author":"Goedde","year":"1971","journal-title":"Ann NY Acad Sci"},{"key":"10.1124\/jpet.102.033746_bib18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/15563659609013786","article-title":"Administration of purified human plasma cholinesterase protects against cocaine toxicity in mice.","volume":"34","author":"Hoffman","year":"1996","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1124\/jpet.102.033746_bib19","first-page":"354","article-title":"Glycosylation of recombinant proteins: problems and prospects.","volume":"16","author":"Jenkins","year":"1994","journal-title":"Enzymezzmicrobzz Technol"},{"key":"10.1124\/jpet.102.033746_bib20","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"225","article-title":"Pharmacogenetics","author":"Kalow","year":"2001"},{"key":"10.1124\/jpet.102.033746_bib21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/12.3.219","article-title":"A \u201cdirect-coloring\u201d thiocholine method for cholinesterases.","volume":"12","author":"Karnovsky","year":"1964","journal-title":"J Histochem Cytochem"},{"key":"10.1124\/jpet.102.033746_bib22","first-page":"1","article-title":"Behandlung einer alkylphosphatintoxikation mit gereinigter serumcholinesterase.","volume":"11","author":"Klose","year":"1976","journal-title":"Prakt Anaesth"},{"key":"10.1124\/jpet.102.033746_bib23","doi-asserted-by":"crossref","first-page":"22840","DOI":"10.1074\/jbc.272.36.22840","article-title":"The mammalian gene of acetylcholinesterase-associated collagen.","volume":"272","author":"Krejci","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.102.033746_bib24","doi-asserted-by":"crossref","first-page":"29488","DOI":"10.1074\/jbc.M004298200","article-title":"Hierarchy of post-translational modifications involved in the circulatory longevity of glycoproteins. Demonstration of concerted contributions of glycan sialylation and subunit assembly to the pharmacokinetic behavior of bovine acetylcholinesterase.","volume":"275","author":"Kronman","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.102.033746_bib25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/taap.1997.8187","article-title":"Cocaine detoxification by human plasma butyrylcholinesterase.","volume":"145","author":"Lynch","year":"1997","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.102.033746_bib26","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0167-4838(89)90282-3","article-title":"A naturally occurring molecular form of human plasma cholinesterase is an albumin conjugate.","volume":"988","author":"Masson","year":"1989","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.102.033746_bib27","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1006\/taap.1997.8188","article-title":"Therapeutic use of butyrylcholinesterase for cocaine intoxication.","volume":"145","author":"Mattes","year":"1997","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.102.033746_bib28","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/00000542-199510000-00008","article-title":"Enzymatic antagonism of mivacurium-induced neuromuscular blockade by human plasma cholinesterase.","volume":"83","author":"Naguib","year":"1995","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.102.033746_bib29","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1097\/00000542-199505000-00025","article-title":"Human plasma cholinesterase for antagonism of prolonged mivacurium-induced neuromuscular blockade.","volume":"82","author":"Naguib","year":"1995","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.102.033746_bib30","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/bja\/77.3.424","article-title":"Edrophonium and human plasma cholinesterase combination for antagonism of mivacurium-induced neuromuscular block.","volume":"77","author":"Naguib","year":"1996","journal-title":"Br J Anaesth"},{"key":"10.1124\/jpet.102.033746_bib31","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00000542-199605000-00006","article-title":"Enzymatic versus pharmacologic antagonism of profound mivacurium-induced neuromuscular blockade.","volume":"84","author":"Naguib","year":"1996","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.102.033746_bib32","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/00000542-199505000-00027","article-title":"Reversal of intense mivacurium block with human plasma cholinesterase in patients with atypical plasma cholinesterase.","volume":"82","author":"Ostergaard","year":"1995","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.102.033746_bib33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/taap.1997.8160","article-title":"The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase.","volume":"145","author":"Raveh","year":"1997","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.102.033746_bib34","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1124\/mol.53.1.112","article-title":"Role of oligosaccharides in the pharmacokinetics of tissue-derived and genetically engineered cholinesterases.","volume":"53","author":"Saxena","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.102.033746_bib35","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/BF03005113","article-title":"The use of serum cholinesterase in succinylcholine apnea.","volume":"24","author":"Scholler","year":"1977","journal-title":"Can Anaesth Soc J"},{"key":"10.1124\/jpet.102.033746_bib36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/bja\/49.3.269","article-title":"Serum cholinesterase: effect on the action of suxamethonium following administration to a patient with cholinesterase deficiency.","volume":"49","author":"Schuh","year":"1977","journal-title":"Br J Anaesth"},{"key":"10.1124\/jpet.102.033746_bib37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1399-6576.1976.tb05031.x","article-title":"Suxamethonium apnoea terminated with commercial serum cholinesterase.","volume":"20","author":"Stovener","year":"1976","journal-title":"Acta Anaesth Scand"},{"key":"10.1124\/jpet.102.033746_bib38","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.1074\/jbc.M006676200","article-title":"Predicted Michaelis-Menten complexes of cocaine-butyrylcholinesterase: engineering effective butyrylcholinesterase mutants for cocaine detoxication.","volume":"276","author":"Sun","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.102.033746_bib39","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00000542-198110000-00015","article-title":"Succinylcholine neuromuscular blockade in subjects homozygous for atypical plasma cholinesterase.","volume":"55","author":"Viby-Mogensen","year":"1981","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.102.033746_bib40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0026-895X(24)23159-X","article-title":"An improved cocaine hydrolase: the A328Y mutant of human butyrylcholinesterase is 4-fold more efficient.","volume":"55","author":"Xie","year":"1999","journal-title":"Mol Pharmacol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524358240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524358240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.102.033746","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T23:24:39Z","timestamp":1740007479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524358240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["S0022356524358240"],"URL":"https:\/\/doi.org\/10.1124\/jpet.102.033746","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2002,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Wild-Type and A328W Mutant Human Butyrylcholinesterase Tetramers Expressed in Chinese Hamster Ovary Cells Have a 16-Hour Half-Life in the Circulation and Protect Mice from Cocaine Toxicity","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.102.033746","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2002 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}